These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4688552)

  • 21. Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories.
    Lauersen NH; Secher NJ; Wilson KH
    Am J Obstet Gynecol; 1975 Aug; 122(8):947-54. PubMed ID: 1155530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of early amniotomy and parity on induction-to-delivery interval during termination of pregnancy].
    Ephrem-Duron J; Stadler A; Pereira B; Laurichesse-Delmas H; Gallot D
    Gynecol Obstet Fertil; 2016 Jun; 44(6):368-9. PubMed ID: 27131866
    [No Abstract]   [Full Text] [Related]  

  • 23. Ultrasonics in early pregnancy: diagnostic scanning and fetal motor activity.
    Reinold E
    Contrib Gynecol Obstet; 1976; 1():1-148. PubMed ID: 782786
    [No Abstract]   [Full Text] [Related]  

  • 24. Termination of pregnancy by "super coils": morbidity associated with a new method of second-trimester abortion.
    Berger GS; Bourne JP; Tyler CW; Haber RJ; Knisely K; Keith L; Zackler J
    Am J Obstet Gynecol; 1973 Jun; 116(3):297-304. PubMed ID: 4707529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing morbidity in termination of pregnancy.
    Harman CR; Fish DG; Tyson JE
    Am J Obstet Gynecol; 1981 Feb; 139(3):333-7. PubMed ID: 7468705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Midtrimester abortion induced by serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1975 Jan; 121(2):273-6. PubMed ID: 1115134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mifepristone-misoprostol midtrimester abortion: impact of gestational age on the induction-to-abortion interval.
    Gómez O; Borrás A; Rabanal A; Palacio M; Carceller A; Coll O; Gratacós E
    Contraception; 2010 Feb; 81(2):97-101. PubMed ID: 20103444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of prostaglandin f-2-alpha as an abortifacient.
    Kajanoja P; Widholm O
    Ann Chir Gynaecol Fenn; 1974; 63(1):28-34. PubMed ID: 4832153
    [No Abstract]   [Full Text] [Related]  

  • 29. A case report of sacculation of the uterus: diagnosis by ultrasonography.
    Palav AB; Tricomi VT
    Am J Obstet Gynecol; 1973 Jul; 116(6):876-8. PubMed ID: 4715944
    [No Abstract]   [Full Text] [Related]  

  • 30. Cervical ruptures in midtrimester abortions.
    Rajan R; Usha KR
    J Obstet Gynaecol India; 1979 Jun; 29(3):613-9. PubMed ID: 12335921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal changes during induction of midtrimester abortion by prostaglandin F 2 .
    Cantor B; Jewelewicz R; Warren M; Dyrenfurth I; Patner A; Vande Wiele RL
    Am J Obstet Gynecol; 1972 Jul; 113(5):607-15. PubMed ID: 4652766
    [No Abstract]   [Full Text] [Related]  

  • 32. Extraovular prostaglandin F2alpha for early midtrimester abortion.
    Shapiro AG
    Am J Obstet Gynecol; 1975 Feb; 121(3):333-6. PubMed ID: 1115147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iatrogenic secondary infertility caused by residual intrauterine fetal bone after midtrimester abortion.
    Moon HS; Park YH; Kwon HY; Hong SH; Kim SK
    Am J Obstet Gynecol; 1997 Feb; 176(2):369-70. PubMed ID: 9065183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urea and 15-me-prostaglandin F2 alpha for midtrimester abortion.
    Rajan R; Usha Devi L; Usha KR
    J Obstet Gynaecol India; 1979 Apr; 29(2):289-94. PubMed ID: 12335895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of laparoscopy as a minimally invasive procedure in treatment of ruptured uterine scar during second-trimester induction of abortion.
    Zheng Y; Jiang Q; Lv YE; Liu F; Yang L
    J Obstet Gynaecol Res; 2016 Apr; 42(4):464-6. PubMed ID: 26695381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artificial rupture of membranes and uterine activity.
    Gaafar AA; el-Sahwi S; Toppozada HK
    Am J Obstet Gynecol; 1967 Aug; 98(7):913-8. PubMed ID: 6029105
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of prostaglandins for the therapeutic termination of pregnancy.
    Southern EM; Gutknecht GD
    J Reprod Med; 1974 Aug; 13(2):63-6. PubMed ID: 4844515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal uterine rupture during oxytocin-augmented, saline-induced abortion.
    Grimes DA; Cates W; Petitti DB; Pakter J
    Am J Obstet Gynecol; 1978 Mar; 130(5):591-3. PubMed ID: 629317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of the uterus and gestation sac by ultrasound in early normal and abnormal pregnancy.
    Chandra M; Evans LJ; Duff GB
    N Z Med J; 1981 Jan; 93(675):3-5. PubMed ID: 6937802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monitoring of the induction of labour by prostaglandin f2alpha in early pregnancy (author's transl)].
    Wiechell H; Massenbach W
    Geburtshilfe Frauenheilkd; 1974 Sep; 34(9):767-75. PubMed ID: 4437567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.